Elkem’s new investment aims to pilot an industrial biocarbon process for silicon and ferrosilicon production by making use of renewable biocarbon instead of fossil coal. The move is in line with the firm’s sustainable production strategy.

The new oral drug delivery technology – Eudratec Fasteric offers enteric protection and provides rapid release in the upper small intestine. The technology is capable of releasing 90 % of its dose within 30 minutes for effective targeting.

The German Research Center for Artificial Intelligence (DFKI) welcomed Sartorius as its new shareholder and together the companies plan to extend their partnership to develop future-focused tools and AI applications for the production of advanced medications.

Post the acquisition, Optimus Holding will invest more than 273 million dollars in the next few years for the development of microbial-derived immunotherapeutics against respiratory diseases and inflammation, and other projects. The takeover is also expected to strengthen the company’s biotech cluster in Switzerland.

The in-depth background paper on renewable carbon focuses on the definition, strategy, measures and potential of renewable carbon as well as outlines the cornerstones of the transition from fossil carbon to renewable carbon for all organic chemicals and materials.

The 11th colloquium on Process Analytics was held in the historical dome hall of TU Vienna under this motto. The nearly 200 participants were unanimous: process analytics must come out of the ivory tower and finally shed the perception of complexity. How is this to happen? How will the much admired trialogue between device manufacturers, science and industrial users be wrapped up finally?

Messer will secure its leading position in Chinese specialty gases market and now also produces specialty gases in the eastern Chinese city of Suzhou, in Jiangsu province. Therefor the industrial gases specialist invests €33 million.

The 12th edition of the Vogel Pharmaceutical Engineering International Forum (VPEIF) 2020 was successfully held from September 19 – 21 in Taizhou, China Medical City, China. Organised by PharmaTEC China, the event witnessed the participation of 58 exhibitors and a footfall of more than 1,300 people making it even more successful than its earlier edition.

The large-scale sustainable project aims to create a hydrogen and sustainable fuel unit founded on the concept of electrolysis. Expected to be complete in three stages, the electrolysis plant once completed will offer a capacity of 1.3 GW.

The chemical company Sasol has invited interested parties to participate in a ‘Request for Information’ process for the development and demonstration of CO2 utilisation technologies at its South Africa operations.